Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 171

1.

Neutralizing activity induced by the attenuated coxsackievirus B3 Sabin3-like strain against CVB3 infection.

Jrad-Battikh N, Souii A, Oueslati L, Aouni M, Hober D, Gharbi J, Ben M'hadheb-Gharbi M.

Curr Microbiol. 2014 Apr;68(4):503-9. doi: 10.1007/s00284-013-0498-z. Epub 2013 Dec 10.

PMID:
24322405
2.

Generation of protective immune responses against coxsackievirus B3 challenge by DNA prime-protein boost vaccination.

Lan J, Gao Z, Xiong H, Chuai X, Jin Y, Li J, Xian X, Liu G, Xie L, Zhang Y, Wang Y.

Vaccine. 2011 Sep 16;29(40):6894-902. doi: 10.1016/j.vaccine.2011.07.049. Epub 2011 Jul 29.

PMID:
21803097
3.

Temperature-sensitive mutant of coxsackievirus B3 establishes resistance in neonatal mice that protects them during adolescence against coxsackievirus B3-induced myocarditis.

Gauntt CJ, Paque RE, Trousdale MD, Gudvangen RJ, Barr DT, Lipotich GJ, Nealon TJ, Duffey PS.

Infect Immun. 1983 Feb;39(2):851-64.

4.
5.

The viral genetic background determines the outcome of coxsackievirus B3 infection in outbred NMRI mice.

Schmidtke M, Merkle I, Klingel K, Hammerschmidt E, Zautner AE, Wutzler P.

J Med Virol. 2007 Sep;79(9):1334-42.

PMID:
17607777
6.

The substitution U475 --> C with Sabin3-like mutation within the IRES attenuate Coxsackievirus B3 cardiovirulence.

M'hadheb-Gharbi MB, Paulous S, Aouni M, Kean KM, Gharbi J.

Mol Biotechnol. 2007 May;36(1):52-60.

PMID:
17827538
7.

Vaccination with coxsackievirus B3 virus-like particles elicits humoral immune response and protects mice against myocarditis.

Zhang L, Parham NJ, Zhang F, Aasa-Chapman M, Gould EA, Zhang H.

Vaccine. 2012 Mar 16;30(13):2301-8. doi: 10.1016/j.vaccine.2012.01.061. Epub 2012 Jan 31.

PMID:
22306858
8.

Coxsackievirus B3-induced myocarditis. Characterization of stable attenuated variants that protect against infection with the cardiovirulent wild-type strain.

Zhang H, Morgan-Capner P, Latif N, Pandolfino YA, Fan W, Dunn MJ, Archard LC.

Am J Pathol. 1997 Jun;150(6):2197-207.

9.

Attenuation of coxsackievirus B3 by VP2 mutation and its application as a vaccine against virus-induced myocarditis and pancreatitis.

Park JH, Kim DS, Cho YJ, Kim YJ, Jeong SY, Lee SM, Cho SJ, Yun CW, Jo I, Nam JH.

Vaccine. 2009 Mar 18;27(13):1974-83. doi: 10.1016/j.vaccine.2009.01.008. Epub 2009 Jan 23.

PMID:
19168108
10.

Immunogenicity of a DNA vaccine for coxsackievirus B3 in mice: protective effects of capsid proteins against viral challenge.

Kim JY, Jeon ES, Lim BK, Kim SM, Chung SK, Kim JM, Park SI, Jo I, Nam JH.

Vaccine. 2005 Feb 25;23(14):1672-9.

PMID:
15705471
11.

The outcome of coxsackievirus B3-(CVB3-) induced myocarditis is influenced by the cellular immune status.

Leipner C, Grün K, Borchers M, Stelzner A.

Herz. 2000 May;25(3):245-8.

PMID:
10904846
12.

Coxsackievirus-induced chronic myocarditis in murine models.

Gauntt CJ, Tracy SM, Chapman N, Wood HJ, Kolbeck PC, Karaganis AG, Winfrey CL, Cunningham MW.

Eur Heart J. 1995 Dec;16 Suppl O:56-8.

PMID:
8682103
13.
14.

Secondary heterotypic versus homotypic infection by Coxsackie B group viruses: impact on early and late histopathological lesions and virus genome prominence.

Yu JZ, Wilson JE, Wood SM, Kandolf R, Klingel K, Yang D, McManus BM.

Cardiovasc Pathol. 1999 Mar-Apr;8(2):93-102.

PMID:
10724506
15.
16.

Enhanced resistance to coxsackievirus B3-induced myocarditis by intranasal co-immunization of lymphotactin gene encapsulated in chitosan particle.

Yue Y, Xu W, Hu L, Jiang Z, Xiong S.

Virology. 2009 Apr 10;386(2):438-47. doi: 10.1016/j.virol.2009.01.029. Epub 2009 Feb 23.

18.

A group B coxsackievirus/poliovirus 5' nontranslated region chimera can act as an attenuated vaccine strain in mice.

Chapman NM, Ragland A, Leser JS, Höfling K, Willian S, Semler BL, Tracy S.

J Virol. 2000 May;74(9):4047-56.

19.

Group B coxsackievirus myocarditis and pancreatitis: connection between viral virulence phenotypes in mice.

Tracy S, Höfling K, Pirruccello S, Lane PH, Reyna SM, Gauntt CJ.

J Med Virol. 2000 Sep;62(1):70-81.

PMID:
10935991
20.

Development of a enterovirus diagnostic assay system for diagnosis of viral myocarditis in humans.

Lim BK, Ju ES, Lao DH, Yun SH, Lee YJ, Kim DK, Jeon ES.

Microbiol Immunol. 2013 Apr;57(4):281-7. doi: 10.1111/1348-0421.12028.

Supplemental Content

Support Center